MicroRNAs in regulation of triple-negative breast cancer progression D Piasecka, M Braun, R Kordek, R Sadej, H Romanska Journal of cancer research and clinical oncology 144, 1401-1411, 2018 | 181 | 2018 |
FGFR2-driven signaling counteracts tamoxifen effect on ERα-positive breast cancer cells L Turczyk, K Kitowska, M Mieszkowska, K Mieczkowski, D Czaplinska, ... Neoplasia 19 (10), 791-804, 2017 | 52 | 2017 |
Aspects of progesterone receptor (PR) activity regulation-impact on breast cancer progression D Piasecka, AC Składanowski, R Kordek, HM Romańska, R Sądej Postepy biochemii 61 (2), 198-206, 2015 | 45 | 2015 |
FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors–implications for therapy of luminal breast cancer D Piasecka, M Braun, K Kitowska, K Mieczkowski, R Kordek, R Sadej, ... Journal of Experimental & Clinical Cancer Research 38, 1-12, 2019 | 40 | 2019 |
Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells D Piasecka, K Kitowska, D Czaplinska, K Mieczkowski, M Mieszkowska, ... Oncotarget 7 (52), 86011, 2016 | 23 | 2016 |
Tetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cells M Mieszkowska, D Piasecka, P Potemski, S Debska-Szmich, ... Translational Research 207, 44-55, 2019 | 13 | 2019 |
Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli D Piasecka, M Braun, M Mieszkowska, L Kowalczyk, J Kopczynski, ... Neoplasia 22 (11), 576-589, 2020 | 12 | 2020 |
Hormonal receptor status determines prognostic significance of FGFR2 in invasive breast carcinoma M Braun, D Piasecka, B Tomasik, K Mieczkowski, K Stawiski, A Zielinska, ... Cancers 12 (9), 2713, 2020 | 8 | 2020 |
FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer K Mieczkowski, K Kitowska, M Braun, B Galikowska‐Bogut, ... Molecular oncology 16 (15), 2823-2842, 2022 | 5 | 2022 |
Ossifying fasciitis at an extraordinary site–a case report and analysis of diagnostic pitfalls Ł Kowalczyk, M Braun, B Tomasik, D Piasecka, D Michno, J Fijuth, ... Contemporary Oncology/Współczesna Onkologia 23 (2), 121-125, 2019 | 4 | 2019 |
Aspekty regulacji aktywności receptora progesteronu (PR)-znaczenie w progresji raka gruczołu piersiowego D Piasecka, A Składanowski, R Kordek, HM Romańska, R Sądej Postępy Biochemii 61 (2), 2015 | 4 | 2015 |
A ‘real-life’experience on automated digital image analysis of FGFR2 immunohistochemistry in breast cancer M Braun, D Piasecka, M Bobrowski, R Kordek, R Sadej, HM Romanska Diagnostics 10 (12), 1060, 2020 | 2 | 2020 |
Progesterone impairs Herceptin effect on breast cancer cells K Kitowska, A Kowalska, M Mieszkowska, D Piasecka, AC Skladanowski, ... Oncology Letters 15 (2), 1817-1822, 2018 | 2 | 2018 |
Subtype-specific tumour immune microenvironment in risk of recurrence of ductal carcinoma in situ: prognostic value of HER2 J Solek, J Chrzanowski, A Cieslak, A Zielinska, D Piasecka, M Braun, ... Biomedicines 10 (5), 1061, 2022 | 1 | 2022 |
The diagnostic challenge in pulmonary tumour embolism in cancer: a case report and literature review A Zielińska, M Braun, D Piasecka, P Minc, HM Romańska Contemporary Oncology/Współczesna Onkologia 24 (4), 258-262, 2020 | 1 | 2020 |
Upregulation of HIF1-a via an NF-jB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli D Piasecka, M Braun, M Mieszkowska, Ł Kowalczyk, J Kopczynski, ... Neoplasia 22 (11), 2020 | | 2020 |
Inflammatory stimuli promote proliferative dominance of basal-like mammary epithelial cells D Piasecka, M Mieszkowska, M Braun, R Kordek, R Sadej, ... European Journal of Surgical Oncology 44, S29, 2018 | | 2018 |
CD151 regulates activity of ERBB receptors M Mieszkowska, D Piasecka, P Potemski, R Sadej, HM Romanska Acta Biochimica Polonica 65 (S2), 2018 | | 2018 |